Literature DB >> 2380288

Simultaneous analysis of theophylline, caffeine and eight of their metabolic products in human plasma by gradient high-performance liquid chromatography.

T E Leakey1.   

Abstract

A method has been developed for the simultaneous determination of methylxanthines and many of their metabolites in plasma. Specially developed extraction columns (Celute-MX) were used and the extracts were separated on a 25-cm ODS column (particle size, 3 microns) at 50 degrees C with a mobile phase gradient. The compounds were detected with a diode array detector at two analytical wavelengths. The value of drug metabolite ratios has been explored and elevated ratios have been found when metabolic clearance was impaired by disease or co-administered drugs. Large concentrations of pharmacologically active metabolites have been found in renal failure. The assay has proved to be reliable and valuable in the elucidation of therapeutic and metabolic problems involving the methylxanthines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380288     DOI: 10.1016/s0021-9673(01)84196-0

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

2.  Bioassay for Determining the Concentrations of Caffeine and Individual Methylxanthines in Complex Samples.

Authors:  Alejandro E Gutierrez; Prachi Shah; Abigail E Rex; Tien C Nguyen; Saamiha P Kenkare; Jeffrey E Barrick; Dennis M Mishler
Journal:  Appl Environ Microbiol       Date:  2019-11-14       Impact factor: 4.792

3.  Pharmacokinetics of theophylline and its metabolites during acute renal failure. A case report.

Authors:  T E Leakey; A C Elias-Jones; P E Coates; K J Smith
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

4.  Individualization of theophylline infusion rate on the basis of a nonlinear compartmental pharmacokinetic model.

Authors:  G C Nikiforidis; C P Argyropoulos; T I Kassimatis; D S Ithakissios
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.